Lilly bets $3B+ to add China’s Haisco to growing list of partners in five-program pact
Eli Lilly and the Haisco Pharmaceutical Group have yet to disclose what specific indications they plan to prioritize.
Lilly bets $3B+ to add China’s Haisco to growing list of partners in five-program pact Read More »
